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Weight gainThis study investigates the effects of salmon peptide fractions, generated using different enzymatic
hydrolyzation methods, on hepatic lipid metabolism. Four groups of mice were fed a high-fat diet with
20% casein (control group) or 15% casein and 5% of peptide fractions (treatment groups E1, E2 and E4)
for 6 weeks. Weight gain was reduced in mice fed E1 and E4-diets compared to control, despite a similar
feed intake. Reduced plasma and liver triacylglycerol levels in E1 and E4-mice were linked to reduced
fatty acid synthase (FAS) activity and hepatic expression of lipogenic genes. By contrast, plasma and liver
lipids increased in the E2 group, concomitant with increased hepatic FAS activity and D9 desaturase gene
expression. Shotgun lipidomics showed that MUFAs were signiﬁcantly reduced in the E1 and E4 groups,
whereas PUFAs were increased, and the opposite was observed in the E2 group. In conclusion, bioactive
peptides with distinctive properties could potentially be isolated from salmon hydrolysates.
 2015 The Authors. Published by Elsevier Ltd. This is anopenaccess article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The role of dietary protein is to provide the body with essential
amino acids for protein synthesis and energy. Beyond this nutri-
tional role, ingested proteins have a wide range of biological func-
tions affecting protein, glucose and lipid metabolism,
transportation, immune function, blood pressure and hormonal
functions (Chou, Affolter, & Kussmann, 2012). It has been increas-
ingly clear that the dietary source of protein can affect cellular
energy metabolism, and that hydrolyzed peptides can have potent
and speciﬁc bioactive potential (Erdmann, Cheung, & Schroder,
2008). Health beneﬁts from ﬁsh consumption have been attributed
to the n-3 polyunsaturated fatty acids, in particular eicosapen-
taenoic acid (EPA) and docosahexaenoic acid (DHA). However,
recent studies have drawn attention towards proteins from marine
sources, which are considered valuable bioactive components as
their amino acid composition and protein proﬁle differ from terres-
trial sources (Kim, Ngo, & Vo, 2012; Larsen, Eilertsen, & Elvevoll,
2011). According to Kelleher, 7 million tons of ﬁsh byproducts
were discarded as processing waste in 2005 (Kelleher, 2005),which constituted 50% of the total catch being used for human con-
sumption (Rustad, 2003). Fish byproducts can be hydrolyzed
enzymatically, using various techniques, liberating potentially
bioactive peptides incorporated in the parental molecule, accord-
ing to molecule size, stability in water, reﬁned protein and protein
mix. Rodent studies on ﬁsh protein hydrolysates have shown that
marine proteins exhibit cholesterol-lowering (Shukla et al., 2006),
antihypertensive (Je, Park, Kwon, & Kim, 2004; Kim & Mendis,
2006), immunomodulating and antioxidant effects (Ahn, Cho, &
Je, 2015), in addition to reparative properties in the intestine
(Fitzgerald et al., 2005), and increased insulin sensitivity (Pilon
et al., 2011). How ﬁsh protein hydrolysate may affect lipid metabo-
lism in liver is less clear. The liver is the major site of lipid metabo-
lism and both fatty acid oxidation and liponeogenesis are carried
out here. These processes are dependent on rate-limiting enzymes,
e.g., carnitine palmitoyltransferase (CPT)-1 and 2, acetyl-CoA car-
boxylase (ACC), and fatty acid synthase (FAS). Several desaturases
are involved in de novo fatty acid synthesis. The D9 desaturase,
encoded by the gene Scd1, generates monounsaturated fatty acids.
Along with elongases, the D5 and D6 fatty acid desaturases,
encoded by the genes Fads1 and 2, respectively, are important in
the biosynthesis of essential polyunsaturated fatty acids (PUFAs).
Regulation of these enzymes will inﬂuence fatty acid composition
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(Nakamura & Nara, 2004).
In this study, we investigated the effect of three different sal-
mon peptide fractions (designated E1, E2, and E4), generated using
different enzymatic hydrolyzation and microﬁltration methods, on
hepatic lipid metabolism in male C57BL/6J mice. We show that dif-
ferent peptide compositions, generated from the same species of
ﬁsh, varied in their beneﬁcial effects on body weight and lipid
metabolism.2. Materials and methods
2.1. Animals and diets
The animal experiments were carried out with ethical permis-
sion obtained from the Norway State Board for Biological
Experiments and followed the Norwegian Research Councils ethi-
cal guidelines. Nine to ten weeks old male C57BL/6J mice were
housed, 3 per cage, at constant temperature (22 ± 2 C) and humid-
ity (55 ± 5%), and exposed to a 12 h light–dark cycle with unrest-
ricted access to food and tap water. After 1 week of
acclimatization to these conditions, they were divided into 4
groups and fed either a high-fat (HF) diet containing 24% (w/w)
fat (21.3% lard and 2.7% soy oil) and 20% casein (control group,
n = 9), or the HF diet supplemented with protein hydrolysate E1,
E2 or E4 from salmon byproducts (a generous gift from Marine
Bioproducts, Storebø, Norway) (15% casein and 5% peptide, group
E1, E2 and E4, n = 6) ad libitum for 6 weeks. The different salmon
peptide fractions were produced as follows: for fractions E1 and
E2, ﬁsh material (spine) was treated enzymatically with alkaline
protease and a neutral protease and the resulting protein hydroly-
sate was subjected to a second enzymatic treatment. Fraction E1
was treated with an Acid Protease A, while fraction E2 was treated
with the proteolytic enzyme Umamizyme from Aspergillus oryzae.
The ﬁnal hydrolysate was then ﬁltered, using micro- and ultra-ﬁl-
tration, and the size distribution of the peptides analyzed. For both
fractions, more than 50% of the ﬁnal preparation consisted of pep-
tides in the range 200–1200 Da and approximately 25% of the pre-
paration consisted of peptides below 200 Da. Salmon backbones,
including heads, were hydrolyzed with proteolytic Alcalase 2.4 L
(Novozymes, Denmark) and subjected to micro- and ultra-ﬁltra-
tion and constituted peptide fraction E4. Nearly 60% of the ﬁnal
preparation consisted of peptides in the range below 1200 Da.
Amino acid composition of the control and peptide diets is
given in Supplementary Table 1. Diets were packed airtight and
stored at 20 C until used to prevent lipid oxidation. Mice were
housed in groups of three per cage at a constant temperature of
22 ± 2 C and a dark/light cycle of 12/12 h. Body weights of the
mice were measured approximately every seventh day and food
intake was measured 3 times during the study. At sacriﬁce, animals
were fasted overnight, anesthetized with 2% isoﬂurane (Schering-
Plough, Kent, UK) and blood was collected by heart puncture. The
blood was centrifuged, EDTA–plasma separated and frozen prior
to further analysis. Livers were collected and immediately frozen
in liquid nitrogen and stored at 80 C prior to further analysis.2.2. Lipid and fatty acid analysis
Liver lipids were extracted according to Bligh and Dyer (1959),
solvents were evaporated under nitrogen and samples re-dissolved
in isopropanol before analysis. Lipids from liver extracts or plasma
were then measured enzymatically on a Hitachi 917 system (Roche
Diagnostics, Mannheim, Germany), using kits for analyzing total
TAG (GPO–PAP kit, Roche Diagnostics), cholesterol (CHOD–PAP
kit, Roche Diagnostics), and total phospholipids (DiagnosticSystems GmbH, Holzheim, Germany). Fatty acid composition was
analyzed in extracted liver lipid, using gas chromatography, as
described previously by Grimstad et al. (2012).
2.3. Lipidomic analysis
Liver samples were stored at80 C prior to analysis and lipido-
mics analysis was performed on 50–100 mg of liver tissue from
each mouse from two groups, E1 and E2, in addition to the control
group. The tissue samples were pulverized with a CP02 CryoPrep
Dry Pulverization System (Covaris), and resuspended in ice-cold
methanol containing 0.1% butyl-hydroxytoluene (BHT) at a con-
centration of 100 mg/mL.
For lipidomics analysis, lipids were extracted from liver homo-
genates, using a modiﬁed Folch lipid extraction procedure (Ekroos,
Chernushevich, Simons, & Shevchenko, 2002). Samples were
spiked with known amounts of deuterium-labeled or heptade-
canoyl-based synthetic internal standards, serving for quan-
tiﬁcation of the endogenous lipid species, as previously described
(Bergan et al., 2013). The samples were stored at 80 C prior to
mass spectrometry analysis.
Molecular glycerophospholipids, glycerolipids, cholesteryl
esters sphingomyelins and triacylglycerols (TAGs) were analyzed
by shotgun analysis on a hybrid triple quadrupole/linear ion trap
mass spectrometer (QTRAP 5500, ABSCIEX) equipped with a
robotic nanoﬂow ion source (NanoMate HD, Advion Biosciences)
(Stahlman et al., 2009). In shotgun lipidomics a 5 lL volume was
infused at a concentration of 0.5 lg liver/lL. For TAG analysis,
the concentration was diluted to 0.05 lg/lL. The analyses were
performed in both positive and negative ion modes, using multiple
precursor ion scanning (MPIS) and neutral loss (NL)-based meth-
ods (Ekroos et al., 2002, 2003). Sphingolipids were analyzed by
reverse phase ultra-high pressure liquid chromatography (Rheos
Allegro UHPLC, Flux Instruments AG), using an Acquity BEH C18,
2.1  50 mm column with a particle size of 1.7 lm (Waters,
Milford, Massachusetts, USA) coupled to a hybrid triple
quadrupole/linear ion trap mass spectrometer (QTRAP 5500,
ABSCIEX). A 25 min gradient, using 10 mM ammonium acetate in
water with 0.1% formic acid (mobile phase A) and 10 mM ammo-
nium acetate in acetonitrile:2-propanol (4:3, v/v), containing
0.1% formic acid (mobile phase B), was used. The column tempera-
ture was set to 60 C and the ﬂow rate to 500 lL/min. 10 lL sam-
ples were injected. Sphingolipids were monitored, using multiple
reactions monitoring (MRM) as described by Merrill, Sullards,
Allegood, Kelly, and Wang (2005).
The MS data ﬁles were processed, using Lipid Proﬁler™ and
MultiQuant™ software for producing a list of lipid names and peak
areas. The individual lipids measured can be found in
Supplementary Table 2. Masses and counts of detected peaks were
converted into a list of corresponding lipid names. Lipids were nor-
malized to their respective internal standard (Bergan et al., 2013)
and tissue weight to retrieve their concentrations. Data were ana-
lyzed, using the software Tableau Desktop 7.0 and the percentage
differences between the groups (E1 vs. controls and E2 vs. controls)
were estimated in pairwise comparisons, using a Hodges–Lehmann
estimator, and the signiﬁcances were calculated using Wilcoxon
rank-sum t-test.
2.4. Hepatic enzyme activities
Liver samples were homogenized and a post-nuclear fraction
was prepared as previously described (Berge, Flatmark, &
Osmundsen, 1984). The activity of CPT-1 was measured in the pres-
ence and absence ofmalonyl-CoA, as previously described (Vik et al.,
2014). The assay conditions for CPT-2 were identical to CPT-1, apart
from some changes in the reaction mix; BSA and KCN were
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used for the assays. Acyl-CoA oxidase (ACOX)-1 activity was mea-
sured, using 20 lg protein, by a coupled assay, described by Small,
Burdett, and Connock (1985), with some modiﬁcations (Madsen
et al., 1999). Glycerol-3-phosphate acyltransferase (GPAT) activity
was measured, as described by Skorve et al. (1993).
2.5. RNA isolation, cDNA synthesis, and real-time PCR
Total RNA from liver tissue was puriﬁed, using theMagMax total
RNA isolation system (Applied Biosystems, Carlsbad, CA, USA) after
tissue homogenization. The quantity of the RNA was measured
spectrophotometrically, using a NanoDrop 1000 (NanoDrop
Products,Wilmington, DE, USA) and the quality of the RNAwas ana-
lyzed, using the Experion Automated Electrophoresis System (Bio-
Rad Laboratories, Hercules, CA, USA). Quality limit for further use
of RNA was set to a R/Q value ofP7 (out of 10). cDNA was synthe-
sized with 500 ng of RNA per reaction, using High Capacity RNA to
cDNAMastermix (Applied Biosystems). Genes of interest were ana-
lyzed in individual samples from liver, using SYBR Green gene
expression assays, and using primers for acetyl-CoA carboxylase
alpha (Acaca, 50acctgtacaagcagtgtgggct, 30cacatggcctggcttggaggg),
acyl-CoA thioesterase (Acot1, 50ctggcgcatgcaggatc, 30ggcacttttcttg-
gatagctcc), fatty acid desaturase 1 (Fads1, 50ggctcccgggtcatcag,
30acccttgttgatgtggaatgc), (Fads2, 50ggacataaagagcctgcatgtg, 30gg
gcaggtatttcagcttcttc), (Fas, 50ggcatcattgggcactcctt, 30gctgcaag-
cacagcctctct), 3-hydroxy-3-methylglutaryl-coenzyme A reductase
(Hmgcr, 50ccggcaacaacaagatctgtg, 30atgtacaggatggcgatgca), fatty
acid binding protein, liver (L-fabp, 50ccatgactggggaaaaagtc, 30gc-
ctttgaaagttgtcaccat), stearoyl-CoA desaturase (Scd1, 50acgggctccg
gaaccgaagt, 30ctggagatctcttggagcatgtggg). SYBRGreen primerswere
used at concentrations ranging from100 to 200 nMand runwith the
Power SYBR GreenMasterMix (Applied Biosystems) in an ABI Prism
7500 sequence detection system. Gene expression was estimated,
using the average threshold (Ct) value, in triplicate calculated, using
the 2DDCtmethod, according to Livak and Schmittgen (2001), using
hypoxanthine phosphoribosyltransferase 1 (Hprt1, 50ggtgaaaaggac-
ctctcgaagtg, 30atagctaagggcatatccaacaac) as reference gene and one
individual sample in the high-fat group as calibrator.
2.6. Statistics
All values are presented as means ± standard deviation (SD).
One-way ANOVA was used for analysis of differences between
groups, followed by Dunnett’s multiple comparison test between
all groups vs. control when data followed Gaussian distribution
and the Kruskal–Wallis test, with Dunn’s multiple comparison test,
was used when data were not normally distributed. Signiﬁcance
was set to (P < 0.05). All statistics were calculated using
GraphPad Prism 6 for Mac OS X with the exception of the lipido-
mics data where software Tableau Desktop 7.0 was used.3. Results
3.1. Body weight was inﬂuenced by dietary intake of salmon peptide
fractions
C57BL/6J mice, fed high-fat diets with 15% casein and 5% (w/w)
of salmon peptide fractions E1 or E4, demonstrated lower body
weight gain throughout the 6 weeks feeding period (Fig. 1A), as
well as a signiﬁcantly lower total weight gain than did control mice
fed 20% (w/w) casein as protein source (Fig. 1B). By contrast, mice
fed peptide E2 had a body weight curve and total weight gain more
similar to the control group. Feed intake was measured 3 times
during the experiment, and the average feed intakes were similarin control, E2 and E4-fed mice (Fig. 1C), while it was higher in
peptide E1-fed mice, despite the low weight gain in this group. A
small, but signiﬁcant reduction was observed in the liver index
(% liver weight/body weight) of E4-fed mice compared to controls
(Fig. 1D).3.2. The salmon peptide fractions differentially affected plasma lipids
but not bile acid levels
Plasma lipids were measured in samples from fasted animals.
While mice fed peptides E1 and E4 demonstrated signiﬁcantly
lower plasma TAG levels than did the control, the TAG level in mice
fed peptide E2 was elevated (Fig. 2A). The peptide E2 group also
demonstrated elevated levels of total cholesterol, phospholipids
and HDL-cholesterol compared to the control (Fig. 2B–D). No
change was observed in LDL-cholesterol or the HDL/LDL ratio in
any of the feeding groups (Fig. 2E and F), but non-esteriﬁed fatty
acids showed a tendency to increase in the E4 group (Fig. 2G, con-
trol vs. E4, Mann–Whitney, P-value = 0.044). There was a small
increase in plasma bile acids in the E4 group, when measured in
plasma samples pooled from 2 to 4 animals (Fig. 2H). However,
statistical signiﬁcance could not be analyzed (n = 2–3).3.3. The effect of salmon peptide fractions on hepatic enzymes
As the studied salmon peptide fractions affected weight gain
and lipid levels differently in C57BL/6J mice, we analyzed the activ-
ity of hepatic enzymes involved in lipid catabolism and synthesis.
CPT-1 is the rate-limiting enzyme in fatty acid import into
mitochondria for b-oxidation. In mice fed E1, no change was
observed in the activity of CPT-1 (Fig. 3A), or its % inhibition by
malonyl-CoA (Fig. 3B). CPT-2 activity was also unchanged, further
supporting no inﬂuence on mitochondrial b-oxidation in this group
(Fig. 3C). The activity of GPAT, involved in the synthesis of TAG,
was unchanged (data not shown). However, de novo lipogenesis
could be affected, as FAS activity tended to be reduced in E1-fed
mice compared to control-mice (Fig. 3D). In E4 mice, a potential
concomitant increase in b-oxidation and reduction in lipogenesis
was observed; CPT-1 and -2 activities demonstrated small, but sig-
niﬁcantly higher levels than the control, suggesting more CPT-
mediated mitochondrial import of fatty acids in these mice. Also,
FAS activity was signiﬁcantly lower in E4-fed mice than in control
mice. By contrast, E2 mice demonstrated a signiﬁcantly higher FAS
activity than did control mice, suggesting increased de novo
lipogenesis in this group, while CPT-1 and -2 activity were
unchanged.
We further analyzed hepatic expression of genes involved in
fatty acid metabolism. The liver fatty acid binding protein (L-fabp)
was not affected by the diets (Fig. 4A). Acot1, which regulates the
cytosolic levels of acyl-CoA, CoASH and free fatty acids, was signiﬁ-
cantly increased in the E2 and E4 groups compared to control mice
(Fig. 4B). In agreement with the enzyme activity data, Fas gene
expression was signiﬁcantly reduced in the E1 and E4 groups com-
pared to control (Fig. 4C). The expression of another important
gene in fatty acid synthesis, Acaca, was signiﬁcantly decreased in
the E1 group compared to the control (Fig. 4D). The D9 desat-
urase (Scd1) mRNA level tended to be increased in livers from
E2-fed mice, supporting an increase in de novo lipogenesis in this
group (Fig. 4E). There was also indication of a differential effect
on D5 and D6 desaturation of fatty acids, as Fads1was signiﬁcantly
lower expressed in the E4 group vs. the control group (Fig. 4F)
and Fads1 and Fads2 tended to be lower in the E1 group compared
to the control (Fig. 4G). HMG-CoA reductase (Hmgcr), the rate-
limiting enzyme in cholesterol synthesis, was signiﬁcantly reduced
in the E1 and E4 groups compared to the control (Fig. 4H).
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Fig. 1. (A) Body weight curve, (B) weight gain, (C) feed intake, and (D) hepatic index in mice fed a high-fat casein diet (control, n = 9) or a diet where 5% of the protein source
was replaced with 5% of three different salmon protein hydrolysates E1, E2 or E4 (n = 6). Data are shown as means with SD and dissimilar letters indicate signiﬁcantly
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acid composition
To determine if the differently processed peptide fractions
could inﬂuence fatty acid composition, total fatty acids in liver
were analyzed. Saturated fatty acids (SFAs) were unaffected in all
peptide diet groups compared to the control. Largely similar effects
on monounsaturated fatty acid (MUFA) and polyunsaturated fatty
acid (PUFA) composition were observed in the E1 and E4 groups:
While MUFAs tended to be reduced in the E1 group, and were sig-
niﬁcantly reduced in the E4 group (Table 1), n-3 PUFAs were sig-
niﬁcantly increased in the E4 group, and n-6 PUFAs increased in
the E1 group compared to the control (Table 1). The opposite effect
was observed in the liver of E2 mice, where MUFAs increased
strongly, while n-3 and n-6 PUFAs were signiﬁcantly reduced com-
pared to control mice. In line with these results, the D9 desaturase
index, calculated by the ratio C16:1n-7/C16:0 or the ratio C18:1n-
9/C18:0, was increased in the E2 group compared to the control.
The D5 desaturase (n-6) index, calculated by the ratio C20:4n-6/
C20:3n-6, increased in the E1 and E4 group, while the D6 desat-
urase (n-3) index, calculated by the ratio C20:5n-3/C20:4n-3, was
signiﬁcantly increased only in E4 (Table 1). In addition, the D5
desaturase (n-3) index was signiﬁcantly increased in the E4 group
compared to the control, while no change was seen in the D6
desaturase (n-6) index (data not shown).
3.5. Comparison of the effect of salmon peptide fractions on hepatic
lipids
In the enzymatic measurements of lipids from liver extracts, we
found that TAG tended to be reduced by peptides E1 and E4 (E1 vs.control, student’s t-test, P-value = 0.042) (Supplementary Table 3).
Surprisingly, cholesterol showed a small but signiﬁcant increase
in E4 vs. control, while phospholipids were increased by both E1
and E4. However, the total hepatic lipid levels (TAG, cholesterol
and PL) were unchanged in E1 and E4 compared to the control. In
the livers of E2 mice, both TAG and total hepatic lipids were signiﬁ-
cantly increased (Supplementary Table 3), in line with plasma lipid
results.
Since the E1 and E2 salmon peptide fractions were generated
from the same raw-material, but showedopposite effects on hepatic
lipid metabolism, liver samples frommice fed these diets were fur-
ther compared to controls in three separate analytical runs in shot-
gun, sphingolipid and TAG lipidomics. Fig. 5A shows a summary of
the effects of these two salmon protein hydrolysate fractions at
the level of the major lipid classes. In line with the enzymatic mea-
surement, the relative difference (%) of TAG was signiﬁcantly ele-
vated in the E2 group vs. control, and tended to decrease in the E1
group vs. control. Striking differences were also seen with the cera-
mides (Cer) and glycerophosphoethanolamines (PE), which
increased signiﬁcantly in E1 vs. control, diacylglycerols (DAG),
which increased in E2 vs. control, and glycosyl/galactosylceramide
(Glc/GalCer), which were speciﬁcally reduced in E1 vs. control.
The difference in TAG in the E1 group compared to the control
was seen as a reduction in all species of TAG, whereas the E2-diet
primarily increased the TAG species containing short, saturated or
monounsaturated fatty acids compared to the control (Fig. 5B).
The peptide fractions had a prominent different effect on hepatic
ceramide levels. The relative differences of all d18:1 ceramideswere
increasedwith the E1 diet compared to the control,while largely the
opposite effect was observed in the E2 group, apart from a sta-
tistically signiﬁcant increase in Cer (d18:1/18:0) (Fig. 5C).
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Fig. 3. Hepatic enzyme activities in mice fed a high-fat casein diet (control) or a diet where 5% of the protein source was replaced with 5% of three different salmon protein
hydrolysates, E1, E2, and E4, respectively. (A) Carnitine palmitoyltransferase-1 (CPT-1) activity, (B) % inhibition of CPT-1 activity by malonyl-CoA, (C) carnitine
palmitoyltransferase-2 (CPT-2) activity and (D) fatty acid synthase (FAS) activity. Data are shown as means with SD (n = 6) and values signiﬁcantly different from control were
determined by one-way ANOVA (⁄P < 0.05, ⁄⁄P < 0.01).
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Based on recent studies, ﬁsh proteins and peptides have diverse
bioactive properties (Kim & Mendis, 2006). The purpose of our
study was to evaluate the effects of three different fractions of sal-
mon protein hydrolysate on body weight development and plasma
lipids, as well as hepatic lipid metabolism, as the liver is the main
organ maintaining lipid homeostasis. The novel ﬁndings of our
study were the divergent effects on body weight, plasma and hep-
atic TAG levels, hepatic lipogenesis and b-oxidation, and hepatic
fatty acid composition by peptide fractions generated using differ-
ent enzymatic methods.
The groups fed peptide fractions E1 and E4 exhibited a lower
weight gain throughout the study, despite the same or higher feed
intake than control. Furthermore, both E1 and E4-fed groups had
reduced plasma TAG levels and a tendency to reduced liver TAG.
In E1 mice, this was linked to decreased expression of the Fas
and Acaca genes, as well as a tendency to decrease FAS activity.
The reduction in these rate-limiting steps in fatty acid synthesis
indicates a repression of de novo lipogenesis by the E1 peptide.
Similar to E1-fed mice, key enzymes in lipogenesis were signiﬁ-
cantly reduced by E4, and in addition, an increased CPT-1 and -2
activity suggested that increased fatty acid oxidation could have
contributed to the lower body weight and plasma TAG observed
in this group.
The generation of the E2 peptide fraction differed from that of
the E1 peptide fraction in the secondary enzymatic treatment,
and opposite effects were observed in these treatment groups.
E2-fed mice had a body weight gain curve similar to that ofcontrol-fed mice, and importantly, displayed increased hepatic
TAG, as well as plasma TAG, cholesterol, and phospholipid levels.
FAS activity was signiﬁcantly increased by E2, and thus the differ-
ences in plasma and liver TAG could partly be explained by an
opposite regulation of fatty acid synthesis in mice fed the E2 vs.
the E1 and E4 peptide fractions. In support of this, the increased
D9 index, and the tendency to increase in hepatic gene expression
of Scd1, the enzyme performing the crucial D9 unsaturation step
during fatty acid synthesis, indicates stimulated fatty acid synthe-
sis in E2-fed mice. The GPAT activity was not altered in the inter-
vention groups; thus TAG synthesis was probably not affected by
the diets.
A number of studies, using high doses of ﬁsh protein or protein
hydrolysate from Atlantic salmon (15–20% of diet), have demon-
strated reduced plasma cholesterol levels in Wistar rats (Hosomi
et al., 2011; Liaset et al., 2009). This has been linked to increased
plasma bile acid levels, and cholesterol clearance through the bile.
However, in a number of comparable studies in rabbits and mice,
no inﬂuence on plasma cholesterol levels has been shown
(Bergeron & Jacques, 1989; Bjørndal et al., 2013). In line with this,
no plasma cholesterol-reducing effects or increases in plasma bile
acids were observed in the treatment groups compared to control,
despite a reduction in the gene expression of Hmgcr, involved in
cholesterol biosynthesis, in the E1 and E4 groups. This could either
be due to the animal model or the lower dose of salmon protein
hydrolysate used compared to previous studies.
Different sources of protein are assumed to differ in digestibil-
ity, thus contributing unequally to energy supply; other proteins
or peptides are believed to suppress appetite (Nishi, Hara, Asano,
Fig. 4. Hepatic gene expressions in mice fed a high-fat casein diet (control) or a diet where 5% of the protein source was replaced with 5% of three different salmon protein
hydrolysates, E1, E2, and E4, respectively. (A) Fatty acid binding protein, liver (L-fabp), (B) acyl-coenzyme A thioesterase 1 (Acot1), (C) fatty acid synthase (Fas), (D) acetyl-
coenzyme A carboxylase alpha (Acaca), (E) stearyl-coenzyme A desaturase (Scd1), (F) fatty acid desaturase 1 (Fads1), (G) fatty acid desaturase 2 (Fads2), and (H) 3-hydroxy-3-
methylglutaryl CoA reductase (Hmgcr). Data are shown as means with SD (n = 6) and dissimilar letters indicate signiﬁcantly different values.
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Table 1
Hepatic fatty acid composition mice fed a casein control diet or diets with 5% of three
different salmon protein hydrolysates for 4 weeksa.
Fatty acids Control E1 E2 E4
SFAs 34.8 ± 1.4 36.3 ± 0.9 34.2 ± 0.7 35.3 ± 1.3
MUFAs 23.8 ± 6.4 17.8 ± 1.8 31.1 ± 4.1⁄⁄ 18.1 ± 4.4
n-3 PUFAs 9.8 ± 1.4 10.7 ± 0.9 7.7 ± 1.1⁄⁄⁄ 14.1 ± 1.4⁄⁄⁄
n-6 PUFAs 31.4 ± 3.8 34.9 ± 0.7 26.8 ± 2.5⁄⁄⁄ 32.4 ± 1.8
bD9-desat. (C16:0) 0.06 ± 0.03 0.05 ± 0.01 0.10 ± 0.02⁄⁄ 0.05 ± 0.02
bD9-desat. (C18:0) 2.1 ± 1.3 1.2 ± 0.1 3.1 ± 0.9⁄⁄ 1.3 ± 0.5
cD5-desat. 9.5 ± 2.1 13.5 ± 1.2⁄ 9.3 ± 1.3 17.6 ± 4.6⁄⁄⁄
dD6-desat. 0.08 ± 0.02 0.10 ± 0.02 0.11 ± 0.02 0.12 ± 0.03⁄
Data are shown as means ± SD (n = 6–9).
Values signiﬁcantly different from control were determined by one-way ANOVA
(⁄P < 0.05, ⁄⁄P < 0.01, ⁄⁄⁄P < 0.001).
Abbreviations: SFAs, saturated fatty acids; MUFAs, monounsaturated fatty acids,
PUFAs, polyunsaturated fatty acids.
a wt%.
b Delta9 desaturase index (C16:1n-7/C16:0 and C18:1n-9/C18:0).
c Delta5 desaturase index (C20:4n-6/C20:3n-6).
d Delta6 desaturase index (C20:5n-3/C20:4n-3).
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addition, a previous study showed that salmon protein uniquely
protects against body weight gain, independently of feed intake
(Pilon et al., 2011). In support of this, feed intake in the four groups
was unable to explain the divergent effect on body weight. Thus, in
the present study, the distinct peptide or amino acid composition
of each salmon protein hydrolysate-fraction may explain the varia-
tion in body weight gain between the treatment groups
(Supplementary Table 1). The degree of hydrolysis of corn gluten
meal has been reported to affect bioavailability and weight gain
in rats (Jin et al., 2014); however, in our study, the three different
hydrolysates had similar compositions with regard to peptide
sequence size, indicating similar degrees of hydrolysis.
Dietary proteins may play a role in mechanisms affecting fatty
acid composition (Bjørndal et al., 2013; Leveille, Tillotson, &
Sauberlich, 1963). The amino acid composition of the diet has been
shown to inﬂuence lipogenesis and desaturation, as tyrosine
down-regulates hepatic D6 activity (Peluffo, Nervi, Gonzalez, &Fig. 5. Summary of lipid classes (A), TAG species (B), and ceramide species (C) in liver,
control, in mice fed a high-fat casein diet (control) or the replacement with 5% of the pr
⁄P < 0.05 and ⁄⁄P < 0.01.Brenner, 1984), and arginine and leucine can regulate the gene
expression of Scd1 and Fas in muscle and adipose tissue (Madeira
et al., 2014). Here, the amino acid composition did not differ to a
large extent since they were all dominated by amino acids from
casein. However, tyrosine and leucine were higher in the E2 diet
compared to the control, E1 and E4, while arginine was reduced
in the E1 and E4 diets compared to the control and E2. In line with
this, the E1 and E4 groups displayed similar patterns in fatty acid
composition, including an increase in the fatty acid ratios 18:3n-
6/18:2n-6 and 20:4n-6/20:3n-6 compared to the control. These
ratios are commonly used as an index for the activities of D6-
and D5 desaturase, respectively. As also reported by others
(Sjogren et al., 2008), the D5 and D6 desaturation indices are inﬂu-
enced by a number of pathways, and failed to reﬂect the expression
of Fads1 and Fads2. In contrast, Scd1 expression correlated with the
D9 desaturase index in liver. Thus, concomitant with increased
Scd1 expression in E2-mice, an increase in monounsaturated fatty
acids and the D9 desaturase index was observed. Interestingly,
while hepatic MUFA increased, n-3 PUFA and n-6 PUFAs decreased
in the E2 group. The main product of D9 desaturase, oleoyl-CoA
(C18:1), is mainly used to generate TAG (Mauvoisin & Mounier,
2011), and this was reﬂected in the predominant increase in TAG
species containing short MUFAs. Studies investigating the effect
of MUFA supplementation on plasma lipid levels in humans are
inconclusive; however, in rats, a high MUFA amount in a diet con-
taining 40% energy from fat was shown to increase plasma total
cholesterol, TAG and phospholipid levels as compared to a low
dietary MUFA amount (Chang & Huang, 1998). The current study
suggests that an increased hepatic expression of Scd1, and a
corresponding increase in MUFAs incorporated into TAG could lead
to increased VLDL release.
The E1 and E4 diets resulted in increased hepatic PUFA levels,
indicating increased biosynthesis of PUFAs at the expense of
MUFAs. Dietary and endogenous fatty acids, in particular PUFAs,
are involved in metabolic regulation of lipid and glucose metabo-
lism. Thus, the differential peptide-effects on lipid levels could
have been reinforced by their opposite regulation of fatty acids
important in cell signaling.presented as relative molar percentage differences between treatment groups and
otein source with 5% of peptide fraction E1 or E2 (n = 6). Signiﬁcance is indicated as
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niﬁcantly elevated level of ceramides in the E1 group. These waxy
lipid molecules can induce both inﬂammation and insulin resis-
tance (Summers, 2006). Increased ceramide levels in adipose tissue
have been linked to higher levels of liver fat (Kolak et al., 2012);
however, in our study, TAG decreased while ceramides increased
in the liver of E1-fed mice. A reduction in diacylglycerols (DAG)
in the E1 group could be of signiﬁcance in view of its physiological
importance in activating protein kinase C (PKC). PKC phos-
phorylates the hydroxyl-groups of serine and threonine amino acid
residues on several important target proteins and modulates
physiological processes in all cells. In our study, DAG and TAG dis-
played a simultaneous decrease in the E1 group and increase in the
E2 group, relative to control. The signiﬁcant increase of DAG in the
peptide E2 group, combined with increased gene expression of
Scd1, but not in ceramide levels, is similar to ﬁndings in the liver
of patients with non-alcoholic fatty liver disease (Kotronen et al.,
2009). In further studies, it will be interesting to evaluate the effect
of the E1 and E4 ﬁsh protein hydrolysate fractions on animal mod-
els, on NAFLD, as well as obesity and insulin resistance.5. Conclusions
The three different peptide fractions from salmon protein
hydrolysate show diverse effects on weight gain, plasma and liver
lipids and lipid synthesis, suggesting that protein products that are
enzymatically hydrolyzed exhibit distinct and, in some cases,
opposite effects. Thus, prior to their potential use as dietary sup-
plements, it is of importance to analyze protein hydrolysates thor-
oughly to exclude possible negative metabolic effects. Pre-
digestion of proteins gives the opportunity to optimize nutritional
value and bioavailability of the peptides, thus obtaining a more
speciﬁc product regarding its use, either as a balanced food supple-
ment, food aid or simply healthy food.
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